MOMA-313

N/A

Report date: 2024/08/20 14:59:33
NME

Base Information

Drug NameMOMA-313
Drug Alias NameMOMA-313
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA polymerase theta inhibitors
TargetsDNA polymerase theta
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsOvarian Neoplasms +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited KingdomSpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMoma Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMoma Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsOvarian Neoplasms +[5
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A